세계의 호흡 모니터링 기기 시장 : 인사이트, 경쟁 환경 및 시장 예측(-2030년)

Respiratory Monitoring Devices Market by Wearability (Wearable and Non-Wearable), Product Type (Spirometers, Pulse Oximeters, Capnographs, Sleep Tech Devices, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of respiratory disorders and its risk factors, the rising geriatric population prone to respiratory ailments, among others across the globe.

The Respiratory Monitoring Devices market is estimated to grow at a CAGR of 5.73% during the forecast period from 2024 to 2030. The Respiratory Monitoring Devices market is poised for substantial growth owing to the increasing prevalence of respiratory disorders, increasing risk factors associated with respiratory disorders, and the rising geriatric population prone to respiratory ailments, among others during the forecast period from 2024 to 2030.

Respiratory Monitoring Devices Market Dynamics:

According to the World Health Organization (WHO) 2024, it was estimated that worldwide around 262 million people were suffering from asthma in 2019. Also, as per the WHO data on cancer 2022, globally around 2.21 million cases of lung cancer were recorded in 2020.

The rising cases of pneumonia, which is a type of acute respiratory infection affecting the lungs is another factor impacting the growth of the respiratory monitoring devices market. As per the WHO 2021, worldwide pneumonia caused 14% of all deaths of children under 5 years old, killing 740,180 children in 2019.

Moreover, the occurrences of other respiratory disorders such as tuberculosis, pulmonary edema, pneumothorax or atelectasis, asbestosis, and others worldwide will further drive the demand for respiratory monitoring devices, positively impacting the respiratory monitoring devices market.

As per the WHO 2021, worldwide around 10 million people were suffering from tuberculosis (TB) with 5.6 million cases in men, 3.3 million cases in women, and 1.1 million cases in children in 2020. This indicated the growing need for monitoring devices so that timely treatment for TB can be provided.

Thus, the interplay of all the above-mentioned factors is expected to boost the market demand for respiratory monitoring devices, and therefore its overall market during the forecast period from 2024 to 2030.

However, the high cost associated with respiratory monitoring devices, and the stringent regulatory approvals for the devices, among others may act as restraining factors for the overall growth of the Respiratory Monitoring Devices during the forecast period.

Respiratory Monitoring Devices Market Segment Analysis:

Respiratory Monitoring Devices Market by Wearability (Wearable and Non-Wearable), Product Type (Spirometers, Pulse Oximeters, Capnographs, Sleep Tech Devices, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the Respiratory Monitoring Devices market, the spirometers category is projected to hold a considerable market share in 2023. This can be attributed to the various features and applications provided by spirometers, along with the product development activities in the spirometers category, during the forecast period.

Spirometers form a valuable tool for studying multiple respiratory problems such as asthma, chronic obstructive pulmonary disease (COPD), and others. They are also used to evaluate possible respiratory disorders and can be used to test lung functioning before surgery.

Spirometers take into account the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled. The commonly taken measurements by spirometers include Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), and FEV1/FVC.

In March 2021, Vyaire Medical announced the launch of the AioCare mobile spirometry system in more than 15 countries across Europe, the Middle East, and Australia. This clinically proven technology expanded upon Vyaire's deep respiratory diagnostics expertise allowing physicians to promptly diagnose pulmonary diseases including asthma and COPD as accurately as hospital-grade spirometers. It also performs high-quality patient monitoring via advanced digital connectivity at home.

Hence, owing to all the aforementioned factors, the market will experience an increased demand for spirometers, thus driving the respiratory monitoring devices market during the forecast period.

North America is expected to dominate the overall Respiratory Monitoring Devices market:

North America is expected to account for the highest proportion of the Respiratory Monitoring Devices market in 2023, out of all regions. North America is also expected to dominate the overall Respiratory Monitoring Devices market during the given forecast period from 2024 to 2030.

The major factors driving the market for Respiratory Monitoring Devices in North America are the presence of a large patient pool suffering from respiratory disorders, product approvals, and the presence of a sophisticated healthcare infrastructure in the US, among others across the region during the forecast period.

According to data provided by the Centers for Disease Control and Prevention 2023, it was recorded that 24,963,874 people in the United States were suffering from asthma in the year 2021. The source further stated that 4,675,475 children below the age of 18 years, had reported having asthma in 2021, in the United States. In another set of statistics published by the Centers for Disease Control and Prevention 2023, it was stated that around 14.2 million adults were diagnosed with chronic obstructive pulmonary disorder in the year 2021.

The high patient population base associated with respiratory disorders is expected to propel the demand for respiratory monitoring devices in the US, in the upcoming years.

In 2020, Aluna, a portable spirometry device received clearance from the US Food and Drug Administration, which monitors lung health at home without the need to visit the doctor.

Thus, due to the interplay of all the above-mentioned factors, the market growth for respiratory monitoring devices is expected to surge in the United States during the forecast period from 2024 to 2030.

Respiratory Monitoring Devices Market Key Players:

Some of the key market players operating in the Respiratory Monitoring Devices market include Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Seimens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher and Paykel Healthcare, and others.

Recent Developmental Activities in the Respiratory Monitoring Devices Market:

• In February 2024, Masimo announced the FDA clearance of MightySat(R) Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) directly to consumers without a prescription. This clearance brought consumers a pulse oximeter medical device powered by Masimo SET(R) pulse oximetry.
• In September 2023, Alveofit (Roundworks Technologies) received approval from the US Food and Drug Administration (FDA) for its portable digital spirometer, alveoair. The product is part of Alveofit's ecosystem, which provides real-time insights to healthcare professionals and enables timely interventions in respiratory care. These insights can offer predictive analytics along with AI models into respiratory health and allow clinicians to zprioritize cases and deliver quality care.
• In November 2021, Cipla Limited announced the launch of Spirofy(R), India's first pneumotach-based portable, wireless Spirometer, which intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India. This advanced device ensures high result accuracy and individual patient safety using Bacterial Viral Filters. Spirofy(R) is entirely wireless with good battery backup, making it suitable for use in outdoor camps, remote areas with power shortages, or simply providing physicians' flexibility and ease of use.

Key Takeaways from the Respiratory Monitoring Devices Market Report Study:

• Market size analysis for current Respiratory Monitoring Devices size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Respiratory Monitoring Devices market.
• Various opportunities available for the other competitors in the Respiratory Monitoring Devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Respiratory Monitoring Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Respiratory Monitoring Devices market growth in the coming future?

Target audience who can be benefited from this Respiratory Monitoring Devices Market Report Study:

• Respiratory Monitoring Devices product providers
• Research organizations and consulting companies
• Respiratory Monitoring Devices - related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Respiratory Monitoring Devices
• Various end-users who want to know more about the Respiratory Monitoring Devices market and the latest technological developments in the Respiratory Monitoring Devices market.

Frequently Asked Questions for the Respiratory Monitoring Devices Market:

1. What are Respiratory Monitoring Devices?

A respiratory monitor is a device that can be used in a hospital or in the home to monitor respiration rate. These devices measure respiratory rate and heart rate, transmitting real-time data displaying and log values for various time points.

2. What is the market for Respiratory Monitoring Devices?

The Respiratory Monitoring Devices market is estimated to grow at a CAGR of 5.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the Respiratory Monitoring Devices market?

The Respiratory Monitoring Devices market is poised for substantial growth, owing to the increasing prevalence of respiratory disorders, increasing risk factors associated with respiratory disorders, and the rising geriatric population prone to respiratory ailments, among others during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Respiratory Monitoring Devices market?

Some of the key market players operating in the Respiratory Monitoring Devices market include Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Seimens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher and Paykel Healthcare, and others.

5. Which region has the highest share in the Respiratory Monitoring Devices market?

North America is expected to account for the highest proportion of the Respiratory Monitoring Devices market in 2023, out of all regions. The major factors driving the market for Respiratory Monitoring Devices in North America are the presence of a large patient pool suffering from respiratory disorders, product approvals, and the presence of a sophisticated healthcare infrastructure in North America, among others across the region during the forecast period.

Table of Contents

1. Respiratory Monitoring Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Respiratory Monitoring Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Respiratory Monitoring Devices Market Key Factors Analysis

• 5.1. Respiratory Monitoring Devices Market Drivers
  • 5.1.1. Increasing prevalence of respiratory disorders
  • 5.1.2. Increasing risk factors associated with respiratory disorders
  • 5.1.3. Rising geriatric population associated with respiratory ailments
• 5.2. Respiratory Monitoring Devices Market Restraints and Challenges
  • 5.2.1. High cost associated with respiratory monitoring devices
  • 5.2.2. Stringent regulatory approvals for the devices
• 5.3. Respiratory Monitoring Devices Market Opportunities
  • 5.3.1. Rising technological innovations in wearable respiratory monitoring devices

6. Respiratory Monitoring Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Respiratory Monitoring Devices Market Assessment

• 7.1. By Wearability
  • 7.1.1. Wearable
  • 7.1.2. Non-Wearable
• 7.2. By Product Type
  • 7.2.1. Spirometers
  • 7.2.2. Pulse Oximeters
  • 7.2.3. Capnographs
  • 7.2.4. Sleep Tech Devices
  • 7.2.5. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.1.2. Canada Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.1.3. Mexico Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.2. Germany Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.3. United Kingdom Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.4. Italy Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.5. Spain Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.6. Rest of Europe Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.2. Japan Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.3. India Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.4. Australia Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.5. South Korea Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.4.2. Africa Respiratory Monitoring Devices Market Size in USD Million (2021-2030)
    • 7.3.4.3. South America Respiratory Monitoring Devices Market Size in USD Million (2021-2030)

8. Respiratory Monitoring Devices Market Company and Product Profiles

• 8.1. Koninklijke Philips NV
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. ResMed
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Medtronic plc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. GE Healthcare
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Draegerwerk
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Seimens Healthineers
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Nihon Kohden Corporation
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Vyaire Medical, Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Hamilton Medical
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Getinge Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. BD
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Airsep Corporation
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Smiths Medical
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Masimo
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Fisher and Paykel Healthcare
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us